Table 1.
Demographic, clinical and biochemical profiles of patients with type 2 diabetes who had COVID-19 vs. those without.
| Variables | COVID-19 (n, 52) | Non-COVID-19 (n, 56) | P value | |
|---|---|---|---|---|
| Age (y) | 55.21 ± 11.30 | 58.33 ± 9.85 | 0.12 | |
| Sex, n (%) | Males | 32 (47.76) | 35 (52.24) | 0.010 |
| Females | 20 (48.78) | 21 (51.22) | ||
| Duration of diabetes (y) | 10.20 ± 1.28 | 11.87 ± 6.91 | 0.28 | |
| Weight (Kg) | 76.06 ± 12.14 | 74.74.16.30 | 0.63 | |
| Body mass index (Kg/m2) | 27.77 ± 3.73 | 27.25 ± 5.31 | 0.56 | |
| HbA1C (%) | 8.08 ± 1.77 | 8.21 ± 1.76 | 0.70 | |
| Thyroid stimulating hormone (m IU/l) | 4.16 ± 7.71 | 3.14 ± 1.55 | 0.39 | |
| 25-hydroxyvitamin D (ng/ml) | 55.01 ± 33.33 | 39.57 ± 24.3 | 0.09 | |
| Serum albumin (g/dl) | 4.13 ± 0.59 | 4.10 ± 0.47 | 0.82 | |
| Handgrip strength (Kg)a | 27.86 ± 10.47 | 26.15 ± 9.45 | 0.37 | |
| Fatigues score on CFQ | ||||
| Mean fatigue score | 3.90 ± 3.52 | 2.98 ± 3.58 | 0.018 | |
| <4 | 24 (46.15) | 35 (63.50) | 0.08 | |
| >4 | 28 (53.85) | 21 (37.50) | ||
a
As measured by Jamar Hydraulic Hand Dynamometer, CFQ: Chalder Fatigue Scale.